StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-2.91%)

Close on Nov 17, 2026Market cap $383.64KP/E –Yield –

VivoSim Labs cash

Cash and short-term investments held at the end of each period.

VivoSim Labs's cash was $1.67M at Jun 30, 2026. For fiscal 2026 it was $5.02M, down 55.6% from the year before. Over ten years it grew -22.2% a year on average. The highest annual figure on record is $62.75M in fiscal 2017.

Annual cash

PeriodPeriod endValueChange
FY2026Mar 31, 2026$5.02M-55.6%
FY2025Mar 31, 2025$11.31M+289.9%
FY2024Mar 31, 2024$2.90M-81.0%
FY2023Mar 31, 2023$15.30M-46.6%
FY2022Mar 31, 2022$28.68M-23.3%
FY2021Mar 31, 2021$37.36M+36.6%
FY2020Mar 31, 2020$27.36M-25.0%
FY2019Mar 31, 2019$36.48M-16.6%
FY2018Mar 31, 2018$43.73M-30.3%
FY2017Mar 31, 2017$62.75M+1.1%
FY2016Mar 31, 2016$62.09M+23.8%
FY2015Mar 31, 2015$50.14M+238.4%
FY2012Dec 31, 2012$14.82M+4257.9%
FY2011Dec 31, 2011$340.00K+19.3%
FY2010Dec 31, 2010$285.00K+102.1%
FY2009Dec 31, 2009$141.00K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$1.67M-81.6%
Q4 FY2026CQ1 2026Mar 31, 2026$5.02M-55.6%
Q3 FY2026CQ4 2025Dec 31, 2025$4.29M+269.3%
Q2 FY2026CQ3 2025Sep 30, 2025$6.68M+110.4%
Q1 FY2026CQ2 2025Jun 30, 2025$9.06M+46.4%
Q4 FY2025CQ1 2025Mar 31, 2025$11.31M+289.9%
Q3 FY2025CQ4 2024Dec 31, 2024$1.16M-78.1%
Q2 FY2025CQ3 2024Sep 30, 2024$3.17M-58.3%
Q1 FY2025CQ2 2024Jun 30, 2024$6.19M-42.5%
Q4 FY2024CQ1 2024Mar 31, 2024$2.90M-81.0%
Q3 FY2024CQ4 2023Dec 31, 2023$5.30M-73.8%
Q2 FY2024CQ3 2023Sep 30, 2023$7.62M-67.2%
Q1 FY2024CQ2 2023Jun 30, 2023$10.75M-57.8%
Q4 FY2023CQ1 2023Mar 31, 2023$15.30M-46.6%
Q3 FY2023CQ4 2022Dec 31, 2022$20.20M-33.3%
Q2 FY2023CQ3 2022Sep 30, 2022$23.22M-31.3%
Q1 FY2023CQ2 2022Jun 30, 2022$25.47M-29.3%
Q4 FY2022CQ1 2022Mar 31, 2022$28.68M-23.3%
Q3 FY2022CQ4 2021Dec 31, 2021$30.27M+60.7%
Q2 FY2022CQ3 2021Sep 30, 2021$33.79M+91.4%
Q1 FY2022CQ2 2021Jun 30, 2021$36.01M+45.3%
Q4 FY2021CQ1 2021Mar 31, 2021$37.36M+36.6%
Q3 FY2021CQ4 2020Dec 31, 2020$18.84M-38.2%
Q2 FY2021CQ3 2020Sep 30, 2020$17.66M-41.8%
Q1 FY2021CQ2 2020Jun 30, 2020$24.79M-30.2%
Q4 FY2020CQ1 2020Mar 31, 2020$27.36M-25.0%
Q3 FY2020CQ4 2019Dec 31, 2019$30.47M-13.5%
Q2 FY2020CQ3 2019Sep 30, 2019$30.35M-18.8%
Q1 FY2020CQ2 2019Jun 30, 2019$35.49M-10.4%
Q4 FY2019CQ1 2019Mar 31, 2019$36.48M-16.6%
Q3 FY2019CQ4 2018Dec 31, 2018$35.22M-25.6%
Q2 FY2019CQ3 2018Sep 30, 2018$37.36M-26.4%
Q1 FY2019CQ2 2018Jun 30, 2018$39.61M-27.9%
Q4 FY2018CQ1 2018Mar 31, 2018$43.73M-30.3%
Q3 FY2018CQ4 2017Dec 31, 2017$47.34M-32.4%
Q2 FY2018CQ3 2017Sep 30, 2017$50.73M-1.9%
Q1 FY2018CQ2 2017Jun 30, 2017$54.97M–
Q4 FY2017CQ1 2017Mar 31, 2017$62.75M–
Q3 FY2017CQ4 2016Dec 31, 2016$70.00M–
Q2 FY2017CQ3 2016Sep 30, 2016$51.72M–

More VivoSim Labs figures

See a number that looks wrong?